Saturday, February 2, 2013

• Critics Want More Exemptions From U.S. Birth-Control Ruleat Bloomberg (Sat, Feb 2)

Thursday, January 31, 2013

• J&J Gets EU Complaint With Novartis on Pay-for-Delay Dealat Bloomberg (Thu, Jan 31)
• Teva Ends Collaboration on CureTech’s Cancer Medicineat Bloomberg (Thu, Jan 31)

Wednesday, January 30, 2013

• Rogue Immune Cells Tied to MS Point to New Drug Targetat Bloomberg (Wed, Jan 30)

Tuesday, January 29, 2013

• Redhill Seeks Migraine, Oncology Partners After Nasdaq Listingat Bloomberg (Tue, Jan 29)

Monday, January 21, 2013

• Clal Biotech Said to Hire Jefferies for MediWound Unitat Bloomberg (Mon, Jan 21)

Thursday, January 17, 2013

• FTC Says Pay-for-Delay Settlements Rise to Most Since ’03at Bloomberg (Thu, Jan 17)

Tuesday, January 15, 2013

• Aura Migraines Linked to Heart Attack Risk for Womenat Bloomberg (Tue, Jan 15)

Thursday, January 10, 2013

• MagicJack Sinks as Ex-CEO Rebuts Blog: Israel Overnightat Bloomberg (Thu, Jan 10)
• Teva Cites BG-12 Safety in Asking FDA to Add MS Reviewsat Bloomberg (Thu, Jan 10)

Tuesday, January 8, 2013

• Teva Seeks Women’s Health-Care Market Beyond Fertilityat Bloomberg (Tue, Jan 8)

Tuesday, December 18, 2012

• Teva Pharmaceutical Gets $3 Billion Credit Line to Replace Debtat Bloomberg (Tue, Dec 18)

Monday, December 17, 2012

• Teva Enters South Korean Drug Market in Bid to Grow in East Asiaat Bloomberg (Mon, Dec 17)

Sunday, December 16, 2012

• French Care for Everyone Means Unwanted Generic Medicineat Bloomberg (Sun, Dec 16)

Friday, December 14, 2012

• AstraZeneca Wins U.S. Ruling to Block Generic Crestorat Bloomberg (Fri, Dec 14)

Thursday, December 13, 2012

• U.S. Corporate Credit Swaps Rise; Teva Pharmaceutical Plans Bondat Bloomberg (Thu, Dec 13)
• Gazit Discount Narrows on Demand as Teva Sinks: Israel Overnightat Bloomberg (Thu, Dec 13)

Wednesday, December 12, 2012

• Teva Focuses on Central Nervous System, Respiratory Drugsat Bloomberg (Wed, Dec 12)
• Teva Focuses on Central Nervous System, Respiratory Drugsat Bloomberg (Wed, Dec 12)
• LivePerson Targets Share Buyback After Tumble: Israel Overnightat Bloomberg (Wed, Dec 12)

Tuesday, December 11, 2012

• Bullish Teva Bets Hit 7-Month High on Strategy: Israel Overnightat Bloomberg (Tue, Dec 11)
• Teva Licenses Pain Drug, Ends Wound Care Deal in Strategy Shiftat Bloomberg (Tue, Dec 11)

Sunday, December 9, 2012

• Cellcom Cheapens to Partner on Outlook: Israel Overnightat Bloomberg (Sun, Dec 9)

Friday, December 7, 2012

• ‘Pay For Delay’ Drug Accords Get U.S. High Court Scrutinyat Bloomberg (Fri, Dec 7)
• Generic Drug Accords Face Review by U.S. Supreme Courtat Bloomberg (Fri, Dec 7)

Add TEVA.TA News to My Yahoo!